https://www.cancerresearch.org/events/webinars/cancer-immunotherapy-2021-research-look-ahead?utm_source=luminate&utm_medium=email&utm_campaign=webinars&utm_content=jan-2021
A very good webinar from the Cancer Research Institute on the future of immune therapies for cancer.
If you don’t have time to watch it start around the 33 minute mark where he talks about the change taking
place for FDA approvals and that you can have approvals come much earlier than phase 3. Something
that should apply to IMU!
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial, page-39
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
-0.001(1.82%) |
Mkt cap ! $396.8M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.6¢ | 5.4¢ | $443.4K | 8.072M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 3056419 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 120000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |